Nathan L. Mata
Chief Scientific Officer at Belite Bio, Inc (BLTE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 8SEC | BLTEBelite Bio, Inc | Sell Plan | 226440 held (−34%) | $152.45 | $34K | +1.3% |
| May 8SEC | BLTEBelite Bio, Inc | Sell Plan | 42812 held (−97%) | $153.56 | $66K | +0.6% |
| May 8SEC | BLTEBelite Bio, Inc | Sell Plan | 39 held (−25%) | $154.61 | $464 | -0.1% |
| May 8SEC | BLTEBelite Bio, Inc | Sell Plan | 9 | $155.25 | $1K | -0.5% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 81,658 held (−0%) | $151.57 | $1K | +1.9% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 4241,234 held (−26%) | $152.67 | $65K | +1.2% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 1281,106 held (−10%) | $153.42 | $20K | +0.7% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 240866 held (−22%) | $154.41 | $37K | +0.1% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 100766 held (−12%) | $155.97 | $16K | -0.9% |
| May 7SEC | BLTEBelite Bio, Inc | Sell Plan | 100666 held (−13%) | $156.00 | $16K | -1.0% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 1202,546 held (−5%) | $153.92 | $18K | +0.4% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 3632,183 held (−14%) | $154.44 | $56K | +0.0% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 1732,010 held (−8%) | $155.48 | $27K | -0.6% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 1211,889 held (−6%) | $156.53 | $19K | -1.3% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 1551,734 held (−8%) | $157.29 | $24K | -1.8% |
| May 6SEC | BLTEBelite Bio, Inc | Sell Plan | 681,666 held (−4%) | $158.11 | $11K | -2.3% |
| May 5SEC | BLTEBelite Bio, Inc | Sell Plan | 323,634 held (−1%) | $153.50 | $5K | +0.6% |
| May 5SEC | BLTEBelite Bio, Inc | Sell Plan | 2363,398 held (−6%) | $154.24 | $36K | +0.2% |
| May 5SEC | BLTEBelite Bio, Inc | Sell Plan | 3253,073 held (−10%) | $155.21 | $50K | -0.5% |
| May 5SEC | BLTEBelite Bio, Inc | Sell Plan | 2352,838 held (−8%) | $156.57 | $37K | -1.3% |
| May 5SEC | BLTEBelite Bio, Inc | Sell Plan | 1722,666 held (−6%) | $157.49 | $27K | -1.9% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 524,614 held (−1%) | $153.89 | $8K | +0.4% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 2884,326 held (−6%) | $154.38 | $44K | +0.1% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 3463,980 held (−8%) | $155.48 | $54K | -0.6% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 823,898 held (−2%) | $156.24 | $13K | -1.1% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 1063,792 held (−3%) | $157.45 | $17K | -1.9% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 653,727 held (−2%) | $158.35 | $10K | -2.4% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 383,689 held (−1%) | $159.08 | $6K | -2.9% |
| May 4SEC | BLTEBelite Bio, Inc | Sell Plan | 233,666 held (−1%) | $160.00 | $4K | -3.4% |
| May 1SEC | BLTEBelite Bio, Inc | Sell Plan | 425,624 held (−1%) | $155.68 | $7K | -0.8% |
| May 1SEC | BLTEBelite Bio, Inc | Sell Plan | 5175,107 held (−9%) | $156.59 | $81K | -1.3% |
| May 1SEC | BLTEBelite Bio, Inc | Sell Plan | 3404,767 held (−7%) | $157.37 | $54K | -1.8% |
| May 1SEC | BLTEBelite Bio, Inc | Sell Plan | 1014,666 held (−2%) | $158.15 | $16K | -2.3% |
| Apr 30SEC | BLTEBelite Bio, Inc | Sell Plan | 2786,388 held (−4%) | $154.58 | $43K | -0.1% |
| Apr 30SEC | BLTEBelite Bio, Inc | Sell Plan | 2596,129 held (−4%) | $155.52 | $40K | -0.7% |
| Apr 30SEC | BLTEBelite Bio, Inc | Sell Plan | 3395,790 held (−6%) | $156.43 | $53K | -1.2% |
| Apr 30SEC | BLTEBelite Bio, Inc | Sell Plan | 1025,688 held (−2%) | $157.39 | $16K | -1.8% |
| Apr 30SEC | BLTEBelite Bio, Inc | Sell Plan | 225,666 held (−0%) | $158.19 | $3K | -2.3% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 127,654 held (−0%) | $154.65 | $2K | -0.1% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 87,646 held (−0%) | $155.36 | $1K | -0.6% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 537,593 held (−1%) | $156.61 | $8K | -1.4% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 2227,371 held (−3%) | $157.49 | $35K | -1.9% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 627,309 held (−1%) | $158.71 | $10K | -2.7% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 3806,929 held (−5%) | $159.42 | $61K | -3.1% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 1206,809 held (−2%) | $160.27 | $19K | -3.6% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 896,720 held (−1%) | $161.72 | $14K | -4.5% |
| Apr 29SEC | BLTEBelite Bio, Inc | Sell Plan | 546,666 held (−1%) | $162.14 | $9K | -4.7% |
| Apr 28SEC | BLTEBelite Bio, Inc | Sell Plan | 448,622 held (−1%) | $160.83 | $7K | -3.9% |
| Apr 28SEC | BLTEBelite Bio, Inc | Sell Plan | 2808,342 held (−3%) | $161.62 | $45K | -4.4% |
| Apr 28SEC | BLTEBelite Bio, Inc | Sell Plan | 2318,111 held (−3%) | $162.38 | $38K | -4.9% |
| Apr 28SEC | BLTEBelite Bio, Inc | Sell Plan | 4097,702 held (−5%) | $163.56 | $67K | -5.5% |
| Apr 28SEC | BLTEBelite Bio, Inc | Sell Plan | 367,666 held (−0%) | $164.07 | $6K | -5.8% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 749,592 held (−1%) | $157.86 | $12K | -2.1% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 1909,402 held (−2%) | $158.65 | $30K | -2.6% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 3759,027 held (−4%) | $159.46 | $60K | -3.1% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 3308,697 held (−4%) | $160.40 | $53K | -3.7% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 288,669 held (−0%) | $161.22 | $5K | -4.2% |
| Apr 27SEC | BLTEBelite Bio, Inc | Sell Plan | 38,666 held (−0%) | $162.53 | $488 | -4.9% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 26710,399 held (−3%) | $164.47 | $44K | -6.1% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 15810,241 held (−2%) | $165.38 | $26K | -6.6% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 12710,114 held (−1%) | $166.56 | $21K | -7.2% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 3739,741 held (−4%) | $167.37 | $62K | -7.7% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 549,687 held (−1%) | $168.43 | $9K | -8.3% |
| Apr 24SEC | BLTEBelite Bio, Inc | Sell Plan | 219,666 held (−0%) | $169.56 | $4K | -8.9% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 3111,635 held (−0%) | $165.70 | $5K | -6.8% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 2011,615 held (−0%) | $166.32 | $3K | -7.1% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 14111,474 held (−1%) | $167.42 | $24K | -7.7% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 10111,373 held (−1%) | $168.64 | $17K | -8.4% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 10511,268 held (−1%) | $169.52 | $18K | -8.9% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 7511,193 held (−1%) | $170.58 | $13K | -9.4% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 25710,936 held (−2%) | $171.62 | $44K | -10.0% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 24910,687 held (−2%) | $172.49 | $43K | -10.4% |
| Apr 23SEC | BLTEBelite Bio, Inc | Sell Plan | 2110,666 held (−0%) | $173.04 | $4K | -10.7% |
| Apr 22SEC | BLTEBelite Bio, Inc | Sell Plan | 6412,602 held (−1%) | $163.49 | $10K | -5.5% |
| Apr 22SEC | BLTEBelite Bio, Inc | Sell Plan | 7812,524 held (−1%) | $164.60 | $13K | -6.1% |
| Apr 22SEC | BLTEBelite Bio, Inc | Sell Plan | 33212,192 held (−3%) | $165.49 | $55K | -6.6% |
| Apr 22SEC | BLTEBelite Bio, Inc | Sell Plan | 31211,880 held (−3%) | $166.49 | $52K | -7.2% |
| Apr 22SEC | BLTEBelite Bio, Inc | Sell Plan | 21411,666 held (−2%) | $167.34 | $36K | -7.7% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 28413,382 held (−2%) | $162.76 | $46K | -5.1% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 52412,858 held (−4%) | $163.52 | $86K | -5.5% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 12412,734 held (−1%) | $164.40 | $20K | -6.0% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 4012,694 held (−0%) | $165.29 | $7K | -6.5% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 312,691 held (−0%) | $166.91 | $501 | -7.4% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 1612,675 held (−0%) | $167.17 | $3K | -7.6% |
| Apr 21SEC | BLTEBelite Bio, Inc | Sell Plan | 912,666 held (−0%) | $168.35 | $2K | -8.2% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 21615,450 held (−1%) | $158.28 | $34K | -2.4% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 21915,231 held (−1%) | $159.81 | $35K | -3.3% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 20115,030 held (−1%) | $160.35 | $32K | -3.7% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 24014,790 held (−2%) | $161.61 | $39K | -4.4% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 7614,714 held (−1%) | $162.26 | $12K | -4.8% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 3614,678 held (−0%) | $163.21 | $6K | -5.3% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 1214,666 held (−0%) | $164.12 | $2K | -5.9% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 3214,634 held (−0%) | $158.46 | $5K | -2.5% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 5214,582 held (−0%) | $159.38 | $8K | -3.1% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 22614,356 held (−2%) | $160.55 | $36K | -3.8% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 27414,082 held (−2%) | $161.41 | $44K | -4.3% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 21613,866 held (−2%) | $162.48 | $35K | -4.9% |
| Apr 20SEC | BLTEBelite Bio, Inc | Sell Plan | 20013,666 held (−1%) | $163.33 | $33K | -5.4% |
| Apr 16SEC | BLTEBelite Bio, Inc | Sell Plan | 38316,283 held (−2%) | $167.58 | $64K | -7.8% |
| Apr 16SEC | BLTEBelite Bio, Inc | Sell Plan | 53715,746 held (−3%) | $168.64 | $91K | -8.4% |
| Apr 16SEC | BLTEBelite Bio, Inc | Sell Plan | 6815,678 held (−0%) | $169.15 | $12K | -8.7% |
| Apr 16SEC | BLTEBelite Bio, Inc | Sell Plan | 815,670 held (−0%) | $170.77 | $1K | -9.5% |
| Apr 16SEC | BLTEBelite Bio, Inc | Sell Plan | 415,666 held (−0%) | $171.19 | $685 | -9.8% |
- Sell
Chief Scientific Officer Nathan L. Mata sold $34K of BLTE at $152.45 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Nathan L. Mata sold $66K of BLTE at $153.56 — cuts the stake by 97%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Nathan L. Mata sold $464 of BLTE at $154.61 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Nathan L. Mata sold $1K of BLTE at $155.25 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Nathan L. Mata sold $1K of BLTE at $151.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Nathan L. Mata sold $65K of BLTE at $152.67 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.